The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCropper (J) Regulatory News (CRPR)

Share Price Information for Cropper (J) (CRPR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 265.00
Bid: 260.00
Ask: 270.00
Change: 0.00 (0.00%)
Spread: 10.00 (3.846%)
Open: 265.00
High: 265.00
Low: 265.00
Prev. Close: 265.00
CRPR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

23 Mar 2022 07:00

RNS Number : 6765F
Cropper(James) PLC
23 March 2022
 

23rd March 2022

 

Trading Update

James Cropper plc (AIM: CRPR)

 

James Cropper plc ('CRPR' or the 'Group'), the leading advanced materials and paper products group, today issues an update on trading and the impact of worldwide wholesale gas price rises.

 

As previously announced, the Group has experienced strong demand throughout the year and across all divisions, with over 30% sales growth in the current year to 26th March 2022, which is ahead of previous market expectations.

 

However, as a direct result of the wholesale gas price increases impacting Q4 and subsequently, the profitability of the Paper division, our expectations for the full year will be for adjusted* PBT for the Group of £3.5M (FY2021: £1.1M) against previous market expectations of adjusted* PBT of £4.9M.

 

While the situation in Ukraine has resulted in uncertainty concerning the Paper division's input costs in the short term, the long term opportunity for the Group remains positive, and we are encouraged by our ability to flex pricing to respond to rising input costs. Building on a strong track record of growth, the year is expected to deliver a new sales high across the Group. We continue to maintain a strong financial position, with transformation programmes well in advance to transition away from natural gas across all Group divisions.

 

The Group has recently secured new credit facilities to support investments and other growth programmes. The £4m Government provided COVID related loan facility, CLBIL, has been repaid in full and undrawn facilities stand comfortably at £20m.

 

 

Technical Fibre Products (TFP)

TFP was nominally impacted during the prior pandemic year and has demonstrated over 20% growth this year, which will exceed market expectations whilst maintaining pre-pandemic margin levels. The outlook for TFP, which is not significantly exposed to energy costs, remains strong. The new production line, commissioned in 2021 and adding 50% production capacity, is now fully operational and is being utilised to support additional demand from hydrogen markets with further capacity required beyond 2024.

 

TFP Hydrogen, acquired in January 2021, is performing well compared to our expectations. The strategic rationale for the acquisition has been proven and it has added a significant new set of complementary products and services to TFP's core offerings building further on our hydrogen proposition. Additional production capacity has been introduced in the US in preparation to support local markets. Further hydrogen plating capacity is planned for TFP to meet the needs of strong market demand.

 

Colourform

Colourform, which had grown by 9% during the previous pandemic year, is expected to have further sales growth of 20% this year. New contracts have been awarded and commercialised in the wine, spirits, and perfume markets, delivering renewable and recyclable packaging to leading global brands such as Ruinart, L'Oréal and Dries Van Noten. The outlook for Colourform, which is not significantly exposed to energy costs, remains unchanged.

The business has invested in product design and print capability and will continue to invest in further capacity and capability.

Paper

Paper was the most significantly impacted part of the Group through the previous pandemic year. Nevertheless, all customers were retained, and demand has quickly returned. With new additional customers and contracts won, sales have grown over 30% in the year.

 

The start of the Russia/Ukraine conflict and the resulting jump in energy costs has, however, significantly affected Paper, which is by far our most energy-intensive division, The average wholesale gas price has moved from 50p/therm to over 250p/therm, peaking at 800p/therm in Q4. This has materially impacted the recent profitability of the division. Actions have been taken: in addition to recent price increases, a customer energy surcharge is being implemented to mitigate the impact moving forward.

 

Plans to decarbonise the Paper division have already been made. The plan is to move away from gas entirely by 2030. Towards this end, some technologies have been implemented in the current year. These, combined with additional advances to come this next year, will reduce our carbon emissions and our dependence on gas.

 

Paper will continue to drive the product portfolio towards higher-value products, supported by investment in additional embossing capacity.

 

 

Other information

 

The financial information on which this trading statement is based has not been reviewed and reported on by the external auditors.

 

Year-end results

The results for the year ending 26 March 2022 are scheduled for release on 21 June 2022.

 

*Adjusted for IAS 19 impact

 

For further information please contact:

 

Enquiries:

James Cropper PLC (AIM: CRPR)

Phil Wild, Chief Executive Officer

Isabelle Maddock, Chief Finance Officer

Jim Aldridge, Company Secretary

Tel: +44 (0) 1539 722002

www.jamescropper.com

Shore Capital

Robert Finlay, Henry Willcocks

John More

Tel: + 44 (0) 20 7601 6100

 

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU No. 596/2014) (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of the UK MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBKBBQDBKBANB
Date   Source Headline
12th Mar 20243:06 pmRNSDirector/PDMR Shareholding
8th Mar 20242:25 pmRNSDirector/PDMR Shareholding
17th Jan 20247:00 amRNSTrading Update
12th Jan 20247:00 amRNSDirectorate Update
21st Dec 20233:33 pmRNSDirector/PDMR Shareholding
20th Dec 20237:00 amRNSGrant of Awards under Long Term Incentive Plan
27th Nov 20237:00 amRNSBoard Appointment
24th Nov 20232:30 pmRNSDirectorate Change
9th Nov 20237:00 amRNSInterim Results
26th Oct 20237:00 amRNSNotice of Interim Results
26th Sep 20232:50 pmRNSResult of Annual General Meeting
26th Sep 20237:00 amRNSAGM Trading Update
4th Sep 20237:00 amRNSNotice of AGM
31st Aug 20237:00 amRNSInnovative production unit for green hydrogen
29th Aug 202312:43 pmRNSDividend Declaration
24th Aug 20237:00 amRNSFull Year Results
10th Aug 20237:00 amRNSNotice of Full Year Results
14th Jun 20237:00 amRNSDirectorship Change
7th Jun 20237:00 amRNSTFP HYDROGEN ANNOUNCES EXPANSION IN NORTH AMERICA
21st Apr 20235:18 pmRNSDirector/PDMR Shareholding
19th Apr 20237:00 amRNSTrading Update and Overview of Strategy
14th Feb 202312:00 pmRNSDirector/PDMR Shareholding
1st Feb 20237:00 amRNSDirector/PDMR Shareholding
31st Jan 20239:45 amRNSDirector/PDMR Shareholding
2nd Dec 20227:00 amRNSDirector/PDMR Shareholding
18th Nov 20229:48 amRNSDirector/PDMR Shareholding
15th Nov 20227:00 amRNSHalf-year Report
31st Oct 20227:00 amRNSHalf Year Trading Update
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
12th Sep 202211:03 amRNSDirector/PDMR Shareholding
2nd Sep 20224:40 pmRNSSecond Price Monitoring Extn
2nd Sep 20224:35 pmRNSPrice Monitoring Extension
26th Aug 20227:00 amRNSDirector/PDMR Shareholding
10th Aug 20227:00 amRNSDirectorship Change
5th Aug 202211:45 amRNSDirector/PDMR Shareholding
27th Jul 202211:00 amRNSQ1 Trading Update and AGM Statement
19th Jul 20227:00 amRNSDirector/PDMR Shareholding
8th Jul 202210:34 amRNSDirector/PDMR Shareholding
7th Jul 20227:00 amRNSDirector/PDMR Shareholding
23rd Jun 202210:25 amRNSNotice of AGM and Annual Report & Accounts
21st Jun 20227:00 amRNSFinal Results
12th May 202212:01 pmRNSHolding(s) in Company
24th Mar 20227:00 amRNSDirector/PDMR Shareholding
23rd Mar 20227:00 amRNSTrading Update
26th Jan 20222:30 pmRNSDirector/PDMR Shareholding
21st Jan 202212:15 pmRNSDirector/PDMR Shareholding
20th Jan 202210:30 amRNSDirectorate Change
12th Jan 20222:00 pmRNSCorrection to Director/PDMR Shareholding
12th Jan 20227:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.